Heart Disease Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Heart Disease Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hypertension
Research on hypertension detailed by scientists at University of Paris
December 28th, 2008
According to a study from Clamart, France, "Oral sildenafil and intravenous epoprostenol have independently been shown to be effective in patients with pulmonary arterial hypertension. To investigate the effect of adding oral sildenafil to long-term intravenous epoprostenol in patients with pulmonary arterial hypertension." "A 16-week, double-blind, placebo-controlled, parallel-group study. Multinational study at 41 centers in 11 countries from 3 July 2003 to 27 January 2006. 267 patients with pulmonary arterial hypertension ( idiopathic, associated anorexigen use or connective tissue disease, or corrected congenital heart disease) who were receiving long-term...
Source: Heart Disease Weekly (2008-12-28)
|
